Cibachron Blue 3GA

ID: ALA134193

Chembl Id: CHEMBL134193

Cas Number: 29225-66-9

PubChem CID: 172468

Max Phase: Preclinical

Molecular Formula: C29H17ClN7Na3O11S3

Molecular Weight: 774.17

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Cibacron Blue 3Ga | C.I. Reactive Blue 2, trisodium salt|70161-13-6|29225-66-9|trisodium;1-amino-4-[4-[[4-chloro-6-(2-sulfonatoanilino)-1,3,5-triazin-2-yl]amino]-3-sulfonatoanilino]-9,10-dioxoanthracene-2-sulfonate|Sodium 1-amino-4-((4-((4-chloro-6-((2-sulfonatophenyl)amino)-1,3,5-triazin-2-yl)amino)-3-sulfonatophenyl)amino)-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate|CHEMBL134193|2-Anthracenesulfonic acid, 1-amino-4-((4-((4-chloro-6-((2-sulfophenyl)amino)-1,3,5-triazin-2-yl)amino)-3-sulfophenShow More

Canonical SMILES:  Nc1c(S(=O)(=O)[O-])cc(Nc2ccc(Nc3nc(Cl)nc(Nc4ccccc4S(=O)(=O)[O-])n3)c(S(=O)(=O)[O-])c2)c2c1C(=O)c1ccccc1C2=O.[Na+].[Na+].[Na+]

Standard InChI:  InChI=1S/C29H20ClN7O11S3.3Na/c30-27-35-28(33-16-7-3-4-8-19(16)49(40,41)42)37-29(36-27)34-17-10-9-13(11-20(17)50(43,44)45)32-18-12-21(51(46,47)48)24(31)23-22(18)25(38)14-5-1-2-6-15(14)26(23)39;;;/h1-12,32H,31H2,(H,40,41,42)(H,43,44,45)(H,46,47,48)(H2,33,34,35,36,37);;;/q;3*+1/p-3

Standard InChI Key:  KIRKGWILHWJIMS-UHFFFAOYSA-K

Associated Targets(Human)

P2RY1 Tchem Purinergic receptor P2Y1 (1327 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FUT8 Tbio Alpha-(1,6)-fucosyltransferase (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2rx1 P2X purinoceptor 1 (52 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P2rx2 P2X purinoceptor 2 (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P2rx4 P2X purinoceptor 4 (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 774.17Molecular Weight (Monoisotopic): 773.0071AlogP: 3.85#Rotatable Bonds: 9
Polar Surface Area: 298.03Molecular Species: ACIDHBA: 15HBD: 7
#RO5 Violations: 3HBA (Lipinski): 18HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: -4.66CX Basic pKa: 1.05CX LogP: -0.75CX LogD: -1.08
Aromatic Rings: 5Heavy Atoms: 51QED Weighted: 0.08Np Likeness Score: -0.51

References

1. Jacobson KA, Jarvis MF, Williams M..  (2002)  Purine and pyrimidine (P2) receptors as drug targets.,  45  (19): [PMID:12213051] [10.1021/jm020046y]
2. Baqi Y, Hausmann R, Rosefort C, Rettinger J, Schmalzing G, Müller CE..  (2011)  Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.,  54  (3): [PMID:21207957] [10.1021/jm1012193]
3. Tedaldi L, Wagner GK.  (2014)  Beyond substrate analogues: new inhibitor chemotypes for glycosyltransferases,  (8): [10.1039/C4MD00086B]
4. Fiene A, Baqi Y, Malik EM, Newton P, Li W, Lee SY, Hartland EL, Müller CE..  (2016)  Inhibitors for the bacterial ectonucleotidase Lp1NTPDase from Legionella pneumophila.,  24  (18): [PMID:27522579] [10.1016/j.bmc.2016.07.027]

Source